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ABSTRACT
Systematic tandem-affinity-purification (TAP) of
protein complexes was tremendously successful in
yeast and has changed the general concept of
how we understand protein function in eukaryotic
cells. The transfer of this method to other model
organisms has been difficult and may require
specific adaptations. We were especially interested
to establish a cell-type-specific TAP system for
Caenorhabditis elegans, a model animal well
suited to high-throughput analysis, proteomics and
systems biology. By combining the high-affinity
interaction between in vivo biotinylated target-
proteins and streptavidin with the usage of a newly
identified epitope of the publicly shared SB1
monoclonal antibody we created a novel in vivo
fluorescent tag, the SnAvi-Tag. We show the versa-
tile application of the SnAvi-Tag in Escherichia coli,
vertebrate cells and in C. elegans for tandem affinity
purification of protein complexes, western blotting
and also for the in vivo sub-cellular localization of
labelled proteins.
INTRODUCTION
Molecular identiﬁcation of protein complexes with
mass spectrometry (MS) has a high potential to answer
many important biological questions. However, one must
be able to purify speciﬁc hetero-multimeric protein
complexes in suﬃcient amounts without contamination
of unrelated proteins. In order to maintain the integrity
of the native protein complex puriﬁcation strategies
employing non-denaturing buﬀer conditions are essen-
tially required.
Tandem tags with variable combinations of small
peptide-tags (1), protein-binding domains (2) or whole
protein tags (3–5) are commonly used to obtain such con-
ditions. Frequently, a recognition site for a sequence-
speciﬁc protease is located between the two tags. The
ﬁrst described tandem tag, the tandem-aﬃnity-puriﬁcation
(TAP)-tag, consists of a combination of an IgG binding
domain and the calmodulin-binding peptide (CBP)
separated by a Tobacco Etch Virus (TEV)-protease recog-
nition site (2). This combination allows the puriﬁcation of
the tagged protein complexes in two steps: after the ﬁrst
puriﬁcation step, the protein complexes can be eluted
in mild buﬀer conditions using protease cleavage. In a
subsequent step, the tagged protein can be enriched
again with an aﬃnity matrix that binds the second part
of the tag.
This tag has earned many merits in yeast but there are
some drawbacks in other types of cells, in which the
respective combination of aﬃnity tags may be sub-optimal
or even fail. Possible reasons for this failure could be high
concentrations of Ig- or calmodulin domains in the sample
which might interact with the tag structure in an
unfavourable way.
Thus, several groups have made modiﬁcations of the
classical TAP-tag and substituted especially the CBP by
other tags (6–8).
Another important feature is the in vivo visualization of
the tagged protein within an organism or at the sub-
cellular level. Mislocalization of a tagged protein could
indicate that co-puriﬁed proteins are false-positive
interactors, resulting from either ectopic expression or
overexpression.
To include such a feature the ‘localization and aﬃnity
tag (LAP-tag) was developed (4) in which the green ﬂuo-
rescent protein (GFP, 9) is part of the tandem tag. Thus,
the GFP can be used at ﬁrst for in vivo analysis of a tagged
protein. A co-immunoprecipitation with a-GFP antibody
enables the ﬁrst puriﬁcation step with this LAP-tag. After
its cleavage by the TEV-protease the S-tag (10) is bound to
a S-protein matrix. In principle, this LAP-tag is functional
but since the ﬁrst puriﬁcation step needs the usage of only
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cedure is expensive and cannot be used at large scales or in
high-throughput applications. Alternatively, a modiﬁed
GFP was developed in which several peptide tags are
introduced into a loop of GFP (11).
Puriﬁcation of low-abundant protein complexes
requires a tag with a high binding aﬃnity, because the
tag’s dissociation constant determines the lowest applica-
ble target protein concentration according to the law of
mass action. One of the strongest interactions available in
biochemistry is the interaction of biotin and chicken
avidin or the homologous streptavidin protein from the
bacteria Streptomyces avidinii (12). D-biotin is an essential
vitamin for all organisms and is speciﬁcally transferred by
biotin holoenyzme synthetases (BHS) to biotin carboxyl
carrier proteins (BCCP, 13). The dissociation constant
of the interaction between (strept-)avidin and biotin
is considerably lower (10
 14 to 10
 16M) than all other
interactions commonly used for aﬃnity puriﬁcation. For
example, the dissociation constant for glutathione and
the Glutathione-S-Transferase (GST)-tag is only about
7 10
 9M (14). An artiﬁcial target motif for bio-
tinylation by the Escherichia coli biotin holoenzyme
synthetase birA has already been described (15,16).
This peptide consists of 13 amino acids and is known
as AviTag. It has already been used in diﬀerent
expression systems including bacteria (17), yeast (18),
Sf9 cells (19), mammalian cell culture (20) and even in
mice (21).
Our initial aim was to improve conditions for protein
puriﬁcation from the nematode Caenorhabditis elegans.
Even though several proteomic studies on the puriﬁcation
of protein complexes from C. elegans have been published
(22–24), there is still a need to ameliorate these methods.
Proteomic approaches are often only practicable if highly
speciﬁc antibodies against the protein or a tagged version
of this protein are available (25,26). Unfortunately, many
commercially available anti-peptide antibodies, such as
a-Flag, a-myc or a-HA, are optimized for the use in
vertebrate cells and result in a high cross-reactivity with
non-vertebrate proteomes. This prevents an eﬃcient usage
of these antibodies, e.g. for protein complex puriﬁcations
from C. elegans.
We describe here a novel tag combining several very
advantageous features: the AviTag to enable high-aﬃnity
puriﬁcations, enhanced green ﬂuorescent protein (EGFP)
to enable in vivo localization studies, the TEV-protease
recognition motif to allow elution under non-denaturing
conditions, and the epitope for the publicly available
peptide antibody SB1 that was mapped in this study. All
these features are combined in a single peptide that can be
fused to any protein for TAP from multiple organisms or
expression systems.
MATERIALS AND METHODS
Cloning of the basic SnAvi-Tag coding vectors
The pEGFP-N1 vector backbone (GenBank Accession
no. U55762; Clontech-Takara) was cut with BamHI and
NotI to introduce a dsDNA linker. To obtain this linker
the two oligonucleotides RB4444 (50-GATCCACCGGTT
ACTACCATGGCTCCACGACCATCCAACAAACGT
CTCCAGCAGT-30) and RB4445 (50-CCGGACTGCTG
GAGACGTTTGTTGGATGGTCGTGGAGCCATGG
TAGTAACCGGTG-30) were allowed to anneal. The
linker encodes one SB1 epitope. In addition, standard
PCR conditions were used to amplify the EGFP coding
sequence from the vector pEGFP-N1. The forward primer
RB4432 (50-ACCGGTATGCCACGACCCTCCAACAA
GCGTCTTCAACAGGAGAACCTTTACTTTCAAGG
TCAATTGGAAAATCTCTATTTCCAGGGACCACC
AGCGCCACCACAGATGGTGAGCAAGGGCGAGG
AGCTGTTCACC-30) includes the AgeI restriction site,
the coding sequence for one additional SB1 epitope and
two TEV-recognition motifs. The reverse primer RB4433
(50-GCGGCCGCTTACTCGTGCCACTCGATCTTCT
GGGCCTCGAAGATGTCGTTCAGGCCACCACCCT
CACCCTGTGCTGCCAAATTCTCGCTTGCAGTAG
TTGGAATATCATAATCCTTGTACAGCTCGTCCA
TGCCGA-30) contains the coding sequence for the
AviTag and a NotI restriction site.
The linker, the cut polymerase chain reaction (PCR)-
fragment, and the BamHI and NotI cut EGFP-N1
vector were ligated to obtain the plasmid pBY2727
(CMV::SnAvi).
The plasmid pBY2887 was obtained by the ligation of
a 977bp fragment encoding the SnAvi-Tag into the
AgeI and NotI restriction site of the pTriEx-5 vector
(Novagen). This fragment was cut from pBY2727.
Standard PCR conditions were used to amplify the
Gateway
TM-cassette from the pDEST53 plasmid
(Invitrogen) with the primer pair RB4517 (50-ACCGGT
ATGACAACAAGTTTGTACAAAAAAGC-30) and
RB4518 (50-ACCGGTGGGACGACCACTTTGTACAA
GAAAGC-30). pBY2887 as well as the PCR-fragment
were cut with AgeI and ligated to obtain the plasmid
pBY2807.
To obtain pBY2946, pBY2727 was cut with NheI and
HindIII. The vector pDP#MM016 (27) that contains the
unc-119 rescue element was cut with HindIII and XbaI.
A 5.6-kb fragment from pDP#MM016 and a 4.9-kb
fragment from pBY2727 were ligated to obtain pBY2946.
All four described vectors contain the coding sequence
for the SnAvi-Tag and can be used to generate arbitrary
C-terminal protein fusions with the N-terminus of the
SnAvi-Tag.
In pBY2727 and pBY2946 the SV40 polyadenylation
site is located 30 to the SnAvi-Tag coding sequence,
whereas in pBY2887 and pBY2807 the rabbit globin 30
untranslated region (UTR) is used.
Cloning of SnAvi-Tag fusions
The plasmids pBY3047 (rhgf-2::SnAvi in pTriEx) and
pBY2824 (pink-1::SnAvi in pTriEx) were obtained by the
Gateway
TM-cloning procedure with the LR-Clonase II
enzyme and the destination vector pBY2807 according
to the manufacturer’s protocol (Invitrogen). The respec-
tive complementary DNAs (cDNAs) were obtained from
the C. elegans cDNA library (Open Biosystems).
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was obtained by insertion of the djr-1.1 cDNA fragment
in the NheI and SalI restriction sites of the vector
pBY2727.
The lrk-1 cDNA sequence was cloned into the NheI and
AgeI restriction sites of pBY2727 to yield the plasmid
pBY2742.
To obtain the vector pBY2987 (myo-3::chn-1::SnAviþ
unc-119 rescue) genomic DNA of the C. elegans chn-1 gene
was ampliﬁed with the primer pair RB4885 (50-CGGATC
CGCAACCATGCCTCCGGGTTCAT-30) and RB4886
(50-GGGGTACCATGTCAAGCGGCGCCGAACA-30).
The PCR fragment was digested with BamHI and KpnI.
The promoter of the C. elegans myo-3 gene was obtained
from the plasmid pPD114.95 (gift from A. Fire, Stanford
University, USA) after restriction with HindIII and
KpnI. Both fragments were ligated with the HindIII and
BamHI digested vector pBY2946 (SnAviþunc-119 rescue
element).
Cloning of the SB1 epitope for expression as EGFP
fusion protein
The primer pair RB4881 (50-AGCTTACCATGGACCCA
CGACCATCCAACAAACGTCTCCAGCAGAAG-30)
and RB4882 (50-CTTCTGCTGGAGACGTTTGTTGGA
TGGTCGTGGGTCCATGGTAAGCT-30) was allowed
to anneal as a dsDNA linker. The EGFP-N1 vector was
cut with HindIII and BamHI and ligated with the linker to
obtain the plasmid pBY2947 that encodes SB1-EGFP
under the control of the CMV-promoter.
Cloning of the birA::mCherry coding vectors
The plasmid pmCherry-N1 is a derivative of pEGFP-N1,
in which the EGFP coding sequence was replaced with the
coding sequence of the red-ﬂuorescent protein mCherry
(28). It served as a vector backbone. Genomic DNA of
the TOP10 E. coli strain (Invitrogen) was used to amplify
the birA coding sequence with the primer pair RB4883
(50-CCCGGGATCCAATGAAGGATAACACCGTGCC
AC-30) and RB4884 (50-CCACCGGTGTGGCGATGCT
CCTTTTTTCTGCACTACGCAGG-30). The forward
primer contains a BamHI restriction site, the reverse
primer an AgeI restriction site and the coding sequence
for a small peptide spacer (RSIAT). The cut PCR
fragment was inserted with BamHI and AgeI in
pmCherry-N1. The resulting plasmid pBY2982 (CMV::
birA::mCherry) encodes a red ﬂuorescent birA::mCherry
fusion protein at the 30-end of a CMV promoter. pBY2982
was excised with NheI and HindIII, a 5.6-kb fragment
from pDP#MM016 was digested with XbaI and
HindIII, and a 2.4-kb-long fragment of the promoter for
the C. elegans myo-3 gene was cut from the plasmid
pPD114.95 (gift from A. Fire, Stanford University). All
three fragments were ligated to obtain the plasmid
pBY2983 (Pmyo-3::birA::mCherryþunc-119 (þ) rescue
element).
Cloning of the plasmids for the ﬂuorescence energy
transfer experiment
The myo-3 promoter was excised from the plasmid
pBY2983 with HindIII and KpnI. The chn-1 coding
sequence was cut from the plasmid pBY2987 with KpnI
and BamHI. Both fragments were ligated in the HindIII/
BamHI sites of an EGFP-N1 (Clontech) analogous vector,
in which the EGFP coding sequence was exchanged with
the coding sequence of the cyan ﬂuorescence protein
Cerulean (29) to yield the plasmid pBY3144. ubc-25::
Venus (30) was generated by replacing the EGFP
encoding sequence of ubc-25::GFP (described in 31) with
the coding sequence of the ﬂurophore Venus using NotI
and BamHI. In addition, the unc-119 rescue sequence was
introduced in the NheI and HindIII sites of the vector to
obtain the plasmid pBY3145.
The anti C. elegans synaptobrevin antibody SB1
The mouse monoclonal SB1 antibody was obtained as a
cell culture supernatant from the Developmental Studies
Hybridoma Bank, University of Iowa. From the same
institution we also obtained the SB1 hybridoma cell line
that was developed by Michael Nonet and Gayla
Hadwiger (Washington University in St Louis). The cell
line was re-cloned by Nanotools, Teningen, Germany, and
a production-run of 1l of cell culture supernatant was
performed.
Antibody interaction measurements
The interaction kinetics of the SB1 antibody with the
epitope sequence PRPSNKRLQQTQAQ fused to the
C-terminus of the C. elegans HMG-11 protein were
determined using surface plasmon resonance (SPR) tech-
nology with a Biacore 3000 (Biacore/GE Healthcare)
instrument. The antibody (6.9ng/ml) was adsorbed in
10mM acetate pH 3.5 on a CM5 chromatin immunopre-
cipitation (CHIP) with a ﬂow rate of 10ml/min and
a contact time of 25s. After immobilization with 1-ethyl-
3-(3-dimethylaminopropyl) carbodiimide (EDC) and
N-hydroxysuccinimide (NHS) for 7min the surface was
blocked with ethanolamine and ﬁnally 1270 resonance
units (RUs) were deposited on the CHIP. To enable back-
ground detection within a measurement, a reference
surface was activated and blocked with ethanolamine
and the sample was ﬁrst directed over the reference and
then over the antibody surface. The tagged protein (stock
20mg/ml) was diluted in 50mM Na-phosphate 150mM
NaCl, 0.005% Tween, pH 7.2 and applied in a dilution
series of 79nM, 159nM, 317nM, 635nM and 1270nM.
Between each sample the surface was regenerated with a
low pH step. Measurements were background corrected
and evaluated with the Biacore evaluation software
version 3.1 using the standard Langmuir two molecule
(AþB$AB) interaction model.
Lysis of C. elegans for western blot analysis
For western blot analysis, worms were washed from the
plates with M9 and pelleted by centrifugation. The pellets
were washed with M9 until the supernatant was cleared
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concentrated Roche Protease Inhibitor cocktail was added
(about 1:2 worm volume to volume of RIPA). The
animals were lysed in the presence of glass beads (1-mm
diameter) by alternating vortexing and freezing in liquid
nitrogen.
Western blot analyses
The membranes were stained with the SB1 antibody
(mouse, pure hybridoma supernatant or 4.6mg/ml of
the puriﬁed antibody), the Roche a-GFP antibody
(#11814460001, mouse, 0.4mg/ml), the Abcam a-GFP
antibody (abcam290, rabbit, 1:2000) or the a–b-actin
antibody (#8691002, mouse, MPBio) overnight at 4 C.
Dependent on the detection method either a-mouse
Alexa680 (goat, 1:10000 in Odyssey blocking solution,
Molecular Probes), a-mouse Alexa800 (goat, 1:10000 in
Odyssey blocking solution, LI-COR), a-rabbit Alexa800
(goat, 1:10000, LI-COR, in Odyssey blocking solution) or
a-mouse-HRP (goat, 1:6000 in 3% milk powder in PBST,
Dianova, for detection with ECL) were used as secondary
antibodies. Alternatively, biotinylated proteins were
directly detected with streptavidin coupled to Alexa680
(Molecular Probes).
The detection of the ﬂuorophore coupled secondary
antibodies and Alexa680 coupled streptavidin was per-
formed with the Odyssey Scanner (LI-COR). The detec-
tion of the HRP-coupled secondary antibody was
performed with the chemiluminescence detecting
LAS-4000 image reader (Fujiﬁlm) and SuperSignal West
Pico Chemiluminescent Substrate (Pierce).
Expression of proteins in E. coli
Escherichiacoli of the strain Rosetta were transformed
with pBY3047 (rhgf-2::SnAvi). Transformed bacteria
were grown in 5ml LB-medium at 37 C over-night. The
next day the overnight culture was diluted 1:100 in
LB-medium. The culture was grown until it reached an
OD600 of 0.6. At this stage isopropyl b-D-1-thiogalacto-
pyranoside (IPTG) was added to an end concentration
of 100mM in order to induce protein expression.
The E. coli were incubated for another 6h at 30 C
before being pelleted by centrifugation (20min, 4 C,
6000g). The pellet was lysed in BugBuster
TM (Novagen)
supplemented with protease inhibitor cocktail tablets
(Roche) according to the manufacturer’s protocol.
Expression of tagged proteins in vertebrate cells
HEK293T cells were grown in MEM with Glutamax sup-
plemented with Pen/Strep and 10% fetal bovine serum
(Gibco). Ten micrograms pBY3047 (RHGF-2::SnAvi),
5mg pBY2955 (DJR-1.1::SnAvi), 20mg pBY2824
(PINK-1::SnAvi) or 20mg pBY2742 (LRK-1::SnAvi)
were co-transfected with 2.5mg pBY2982 (birA::
mCherry) each in HEK293T cells that were plated on
10-cm dishes. For transfection, the lipofection reagent
GeneJuice
TM was used according to the manufacturer’s
protocol (Novagen). Additionally, free D-biotin (Sigma-
Aldrich) dissolved in MEM was added prior to trans-
fection to an end concentration of 100mM plus the
endogenous free D-biotin within the medium as described
(20). Twenty-four to forty-eight hours post-transfection
the cells were washed once with phosphate-buﬀered
saline (PBS) and lysed in CytoBuster
TM supplemented
with protease inhibitor cocktail tablets (Roche) according
to the manufacturer’s protocol (Novagen). For the
analysis of the cross-reactivity of the SB1 antibody with
diﬀerent cell lines HeLa cells were grown in the medium
described above. Chicken DT40 cells were cultured in
RPMI1640 Medium supplemented with 1mM l-glutamine,
10% fetal bovine serum, 1% chicken serum, 50mM
2-mercaptoethanol and Pen/Strep (Gibco). The lysates
for both cell lines were prepared as described for
HEK293T cells.
Puriﬁcation of SnAvi-tagged proteins from
HEK293T cells
SnAvi-tagged proteins expressed in HEK293T cells were
allowed to bind to TetraLink-beads (Promega) on a
rotating shaking incubator at 4 C for at least 4h or over-
night. Fifty-percent slurry of the beads was used in a ratio
of 1:2 to the volume of the respective lysates. The beads
were washed with the TEV elution buﬀer (0.5mM EDTA,
1mM DTT, 150mM NaCl, 50mM Tris, pH 8). For
the TEV digestion a ratio of 3:1 bead volume: volume
of TEV elution buﬀer was used. AcTEV protease
(Invitrogen) was added to a ﬁnal concentration of 0.5U/
ml. The digestion was performed at 16–23 C for at least 2h
or overnight. The TEV eluates were either concentrated in
a vacuum centrifuge or directly used for western blot
analysis.
Worm strains
Caenorhabditis elegans strains were cultured as described
by Brenner (32). The Bristol strain N2 was used as
standard wild-type strain. The strain BR3771 carrying
the integrated transgene byIs143 was obtained by micro-
injection (33) of the N2 wild-type strain with myo-2::
dsRed2 (pBY2000) and snb-1::snb-1-GFP (pSB120.65,
kindly provided by M. Nonet), followed by integration
with ultraviolet (UV)-irradiation and eight outcrossing
steps. The strain BR5072 carries the extrachromosomal
array byEx715. This array was obtained by microinjection
of the strain DP38 (unc-119(ed3)) with the plasmids
myo-3::birA::mCherry (pBY2983) and myo-3::chn-1::
SnAvi (pBY2987).
For the ﬂuorescence energy transfer (FRET) experi-
ment, the strain BR5518 (unc-119(ed3);byEx780) was
generated by microinjection of the plasmids pBY3144
and pBY3145 in the strain DP38 (unc-119(ed3)). The
transgene rescues the unc-119 mutation.
Tandem-aﬃnity protein-complex puriﬁcation
from C. elegans
The lysates of the worm strain BR5072 were prepared in
IPP150 buﬀer (10mM Tris–HCl, pH 8, 150mM NaCl,
0.1% NP-40, supplemented with 3  concentrated Roche
protease inhibitor cocktail). Five millilitres of IPP150
buﬀer was used for the lysis of 0.5g worms of the strain
BR5072. The lysates were prepared in the French press
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lyse all animals completely. The lysate was incubated
with 400ml TetraLink beads (Promega) for 30min before
the beads were washed ﬁve times with IPP150 avidin
buﬀer with 1  Roche protease inhibitor cocktail. Two
additional washing steps were performed to exchange
the buﬀer with TEV-cleavage buﬀer [10mM Tris–HCl,
(pH 8), 150mMNaCl, 0.1% NP-40, 0.5mM EDTA,
1mM DTT]. Two-hundred units of AcTEV protease
(Invitrogen) were used in a volume of 1.5ml TEV-
cleavage buﬀer to speciﬁcally cut SnAvi-tagged proteins
from the TetraLink beads (incubation at 16 C, 2h).
The supernatant was incubated with 15ml SB1-coupled
ProteinG agarose beads at 4 C overnight. The coupling of
the SB1 antibody was performed using the Protein Size X
protein G immunoprecipitation kit (Pierce) according to
the manufacturer’s protocol.
After being washed three times with TEV-cleavage
buﬀer, the beads were boiled in 15ml modiﬁed Laemmli
buﬀer [300mM Tris–HCl (pH 6.8), 12mM EDTA, 6%
SDS (w/v), 30% glycerol].
The protein eluate was then allowed to run a few
millimetres intoa12%sodiumdodecylsulphate(SDS)sep-
aration gel. The gel was stained with Coomassie blue and
all co-puriﬁed proteins were excised as a single band from
the gel. This band was used completely for analysis by MS.
MS
In-gel digests were performed as described in standard
protocols. Brieﬂy, the excised gel bands were destained
with 30% ACN, shrunk with 100% ACN, and dried in a
Vacuum Concentrator (Concentrator 5301, Eppendorf,
Hamburg, Germany). Digests with trypsin were performed
overnight at 37 C in 0.05M NH4HCO3 (pH 8). About
0.1mg of protease was used for one gel band. Peptides
were extracted from the gel slices with 5% formic acid.
All liquid chromatography/mass spectroscopy
(LC-MS)/MS analyses were performed on an ion trap
mass spectrometer (Agilent 6340, Agilent Technologies)
coupled to an 1200 Agilent nanoﬂow system with a
high-performance liquid chromatography (HPLC)-CHIP
cube ESI interface. Peptides were separated on a
HPLC-CHIP with an analytical column of 75mm i.d.
and 150mm length and a 40-nl trap column, both
packed with Zorbax 300SB C-18 (5-mm particle size).
Peptides were eluted with a linear acetonitrile gradient
with 1%/min at a ﬂow rate of 300nl/min (starting with
3% acetonitrile).
MS/MS analyses were performed using data-dependent
acquisition mode. After an MS scan (standard enhanced
mode), a maximum of three peptides were selected for
MS/MS (CID, standard enhanced mode). The automated
gain control was set to 350000. The maximum accumula-
tion time was set to 300ms.
Mascot Distiller 2.1 was used for raw data processing
and for generating peak lists, essentially with standard
settings for the Agilent ion trap. Mascot Server 2.2 was
used for database searching with the following param-
eters: peptide mass tolerance: 1.1Da, MS/MS mass toler-
ance: 0.3Da,
13C: 1, enzyme: trypsin with max. two missed
cleavage, variable modiﬁcations: Gln->pyroGlu (N-term.
Q), oxidation (M) and carbamidomethyl (C).
The SwissProt 55.6 and WormPep 194 databases were
used.
Microscopy
An Imager.Z1 microscope equipped with an
AxioCamMRm CCD camera and the Axiovision
software release 4.6 (all Carl Zeiss, Goettingen) were
used for microscopic documentation of C. elegans. For
cell culture observations, the Eclipse TS100 microscope
(40  magniﬁcation) and the Digital Sight DS-2 MBW
camera (both Nikon) were used.
FRET analysis
FRET microscopy of the strain BR5518 was performed
using a Zeiss LSM510-META inverted confocal laser
scanning microscope using the spectral detector in a
virtual ﬁlter mode. Cerulean emission was detected from
471–503nm, FRET-emission and Venus emission were
detected from 524–567nm. We used 457-nm excitation
for Cerulean and FRET and 514-nm excitation for
Venus in a two-track conﬁguration. A C-Apochromat
63 /1.2W objective was used.
Spectral references for ﬁlter bleed-through were taken
from myo-2::Cerulean and myo-2::Venus transgenic
C. elegans strains, respectively. FRET was calculated
with the PixFRET plugin (34) of ImageJ (35) using a
Gaussian blur of 1.0 and a threshold of 0.8. BTdon
(BTacc) was determined as 0.485 (0.742).
RESULTS
Identiﬁcation and characterization of the SB1
binding epitope
The SB1 mouse monoclonal antibody and the respective
hybridoma cell line are publicly distributed by the Devel-
opmental Studies Hybridoma Bank (DSHB). Unlimited
amounts of this antibody that targets the synaptobrevin
protein (SNB-1, 36) of C. elegans (Figure 1D) can be
produced with these hybridoma cells. Since this antibody
did not show cross reactivity with other proteins we
decided to identify the epitope in the SNB-1 sequence.
For this purpose, several diﬀerent fragments of the
SNB-1 protein were expressed in HEK293T cells. The
fragments that were recognized by the antibody were
shortened in several rounds until a 10-amino-acid-long
peptide stretch in the primary SNB-1 sequence was
identiﬁed that is still recognized by the SB1 antibody.
This peptide (SNB-1 17–26) has the amino acid sequence
PRPSNKRLQQ and is recognized in synthetic protein
fusions (Figure 1B). Notably, this antibody can also be
used for protein detection in diﬀerent vertebrate cell
lines and in E. coli due to the fact that no or only very
weak cross reactivity of the antibody with the respective
proteomes is detectable (Figure 1E). The detection thresh-
old of the antibody was determined in western blot
analysis (Figure 1C). For detection, 0.3ng of SB1
epitope tagged HMG-11 protein was suﬃcient.
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the epitope-tagged HMG-11 protein were further
evaluated by SPR measurements. Interaction curves
were ﬁtted with a standard ‘AþB’ Langmuir model. In
the most reliable measurement range of intermediate
sample concentrations (e.g. 317nM) the association rate
constant was ka¼1.4 10
6 2 10
4M
 1s
 1 and the dis-
sociation rate constant kd¼3.4 10
 3 5 10
 5s
 1
resulting in a dissociation constant of KD ¼ 2.4nM.
The structural composition of the SnAvi-Tag allows
a novel puriﬁcation strategy
Since the cross-reactivity of the SB1 antibody with other
proteins was low and the SB1 epitope maintained its reac-
tivity in protein fusions, we selected the SB1 epitope as
one component of our tandem tag. In order to gain avidity
eﬀects and to increase the chance of accessibility of the
epitope in various protein fusions we included two copies
of the SB1 epitope. These two SB1 epitopes were fused to
the C-terminus of our target-proteins and can be used for
both in vitro detection and puriﬁcation. Furthermore,
we incorporated the coding sequence for EGFP in our
tandem tag to facilitate in vivo detection. Since the SB1
epitopes are separated from the EGFP by two TEV
protease recognition motifs, the EGFP can be removed
from the tagged protein during the puriﬁcation procedure.
As a last but very important feature, we also included an
AviTag (15) in our system. This amino acid sequence is
speciﬁcally biotinylated by the E. coli protein–biotin ligase
birA and allows us to work with the biotin–(strept-)avidin
interaction. This interaction is one of the strongest
non-covalent interactions occurring in biochemistry and
has a femtomolar dissociation constant. Using the
AviTag for the ﬁrst protein puriﬁcation step allows us to
purify also proteins of very low abundance. Furthermore,
contaminating proteins can be removed in the ﬁrst puriﬁ-
cation step by using stringent buﬀer conditions. A sche-
matic view of the structure that we named SNB-1 Avi
puriﬁcation tag (SnAvi-Tag) is shown in Figure 2A.
To make use of this tag in a variety of expression
systems we generated several basic vectors in which any
gene of interest can be introduced 50 to the SnAvi coding
sequence (Figure 2B–D). The plasmids pBY2887 and
pBY2807 are derived from the pTriEx-5 vector
(Novagen) that contain the CMV, T7 and P10 promoters
and, thus, can be used for protein expression in either
mammalian, E. coli or Sf9 cells. In pBY2887 a gene of
interest can be introduced in a multiple cloning site
(MCS) by classical cloning procedure. On the other
hand, the vector pBY2807 gives the possibility to intro-
duce a gene of interest by recombination with the help of
the LR Clonase II enzyme (Invitrogen).
The third basic vector we designed (pBY2946,
Figure 2D) is suitable for gene expression in C. elegans.
To simplify the selection of transgenic animals we
included the rescue sequence for unc-119 mutants. This
marker gene allows transgenic unc-119 mutants to enter
the dauer larval stage (27). Thus, only transgenic animals
can survive starvation periods. All described vectors are
available via Addgene.
Expression and puriﬁcation of SnAvi-tagged proteins
in E. coli and HEK293T cells
Since we are interested in the function of the C. elegans
orthologues of Parkinson’s-disease-related genes (37),
Figure 1. Mapping of the SB1 epitope and test of cross reactivity of SB1 in diﬀerent expression systems. (A) The epitope that is recognized by
the SB1 antibody was determined in the peptide sequence of the C. elegans protein SNB-1. (B) The SB1 antibody speciﬁcally detects EGFP when
fused to the SB1 epitope (PRPSNKRLQQ, right lane). However, no signal is detectable in the negative control lacking the SB1 epitope (left lane).
The upper blot is detected with a-GFP. The SB1 antibody is used for the detection of the lower blot. (C) The detection threshold of the SB1 antibody
was determined in western blot analysis with SB1 epitope tagged HMG-11 protein as antigen and HRP-coupled secondary antibody. (D) The SB1
antibody speciﬁcally detects SNB-1 (ﬁlled arrow head) in C. elegans wild-type lysates and additionally in the lysate of the transgenic animal
strain BR3771 also the protein fusion SNB-1::GFP (unﬁlled arrow head). Caenorhabditis elegans lysates were separated in a 12% SDS–PAGE.
(E) Detection of the cross reactivity of the SB1 antibody with the lysates of diﬀerent cell lines and E. coli. Equal amounts of proteins are separated in
a 12% SDS–PAGE, blotted and detected with the SB1 or a–b-actin antibodies. DJR-1.1::SnAvi expressed in HEK293T cells is used as a positive
control. Fluorescent secondary antibodies and the Odyssey scanner (LI-COR) were used for the detection of the western blots (B), (D) and (E).
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pink-1 and lrk-1 in SnAvi-Tag expression vectors.
Furthermore, the functionality of the SnAvi-Tag for the
expression in diﬀerent expression systems should be
demonstrated with the C. elegans guanine nucleotide
exchange factor rhgf-2.
For expression in HEK293T cells the respective vectors
were co-transfected with the birA::mCherry encoding
vector pBY2982. D-biotin (Sigma) was supplemented in
a concentration of 100mM in order to optimize the
biotinylation eﬃciency (20).
When djr-1.1::SnAvi and birA::mCherry were
co-expressed, both proteins could be easily monitored in
living cells. Using ﬂuorescence microscopy we detected
both protein fusions, birA::mCherry as well as DJR-1.1::
SnAvi, independently from each other (Figure 3A). Only
when the birA-encoding plasmid was co-transfected with
djr-1.1::SnAvi in mammalian cells, the fusion protein
could be pulled down from the cell lysates using avidin
beads (Figure 3E). In order to test whether the TEV-
cleavage sites can be recognized within the SnAvi-Tag a
fraction of the avidin beads bound to DJR-1.1::SnAvi was
incubated with the AcTEV-protease (Invitrogen). Subse-
quently, the AcTEV-eluate was incubated with SB1-
bound Protein A/G Sepharose (Santa Cruz) to enrich
DJR-1.1::SB1. The successful TEV-cleavage could be
monitored due to the shift of the protein size after the
removal of the EGFP-AviTag part of the protein fusion
(Figure 3E). The size of the tagged DJR-1.1 protein was
thereby reduced from 57kDa (DJR-1.1::SnAvi) to 26kDa
(DJR-1.1::SB1, Figure 3E).
In a next step, we tested the possibility of using the
SB1-epitope within the SnAvi-Tag for immunopre-
cipitation. LRK-1::SnAvi as well as PINK-1::SnAvi were
expressed and puriﬁed from HEK293T cells. For this
purpose, the SB1 antibody was cross-linked to Protein G
agarose (Pierce). The SB1-cross-linked beads were
incubated with the respective lysates and PINK-1::SnAvi
as well as LRK-1::SnAvi were puriﬁed together with these
beads (Figure 3B or C, respectively), despite of the huge
protein size of LRK-1::SnAvi (>300kDa). Notably, all
puriﬁcation steps described for DJR-1.1::SnAvi worked
as well for both PINK-1::SnAvi and LRK-1::SnAvi
(data not shown).
rhgf-2::SnAvi was used for expression in mammalian
cells and in the Rosetta E. coli strain. For this purpose,
we used the plasmid pBY3047 that contains promoters for
both expression systems. Due to the fact that birA is a
natural E. coli protein recombinantly expressed birA was
not required in this case. RHGF-2::SnAvi could be
detected in both the lysates of the pBY3047 transformed
Rosetta E. coli strain as well as in lysates of pBY3047
transfected HEK293T cells (Figure 3D). In addition, the
biotinylation of RHGF-2::SnAvi was conﬁrmed when
Alexa 680 coupled streptavidin was used for detection
(Figure 3D).
Figure 2. Composition of the SnAvi-Tag and SnAvi coding vectors. The SnAvi-Tag combines several peptide sequences with distinct features: two
epitopes for the SB1 antibody (SB1-Epi1, SB1-Epi2), two recognition motifs for the TEV protease (TEV1, TEV2), the enhanced green ﬂuorescent
protein (EGFP) and the AviTag (Avidity). (A) The E. coli biotin ligase birA speciﬁcally ligates free D-biotin to the AviTag. (B)–(D) Vectors encoding
the SnAvi-Tag. All vectors are available via www.addgene.org (B) The vector pBY2887 contains the coding sequence for the SnAvi-Tag under
control of three diﬀerent promoters (T7P, P10P and CMVP) allowing protein expression from this vector in E. coli, Sf9 and vertebrate cells. The
tagged protein can be introduced in the multiple cloning site (MCS) by standard cloning procedures. (C) The vector pBY2807 shares the basic
structure of pBY2887. Instead of a MCS it contains a cassette (‘Gateway-box’) that allows the introduction of a gene of interest using the
Gateway-technology (Invitrogen). (D) The vector pBY2946 can be used for expression in C. elegans. It contains the coding sequence for the
SnAvi-Tag and the rescue element for the unc-119(ed3) mutant as a genetic selection marker.
PAGE 7 OF 13 Nucleic AcidsResearch, 2010, Vol.38,No. 6 e91Figure 3. The SnAvi-Tag can be used eﬃciently for protein expression and puriﬁcation. (A) DJR-1.1::SnAvi and birA::mCherry can be detected
in vivo. Recombinant protein fusions are visualized with the Eclipse TS100 microscope (40  magniﬁcation) and the Digital Sight DS-2 MBW camera
(both Nikon). The scale bar represents 20mm. PINK-1::SnAvi (B) and LRK-1::SnAvi (C) can be puriﬁed eﬃciently with the SB1-antibody
cross-linked to Protein G Sepharose (Pierce). Most SnAvi-tagged proteins are cleared from the supernatant (SN) after incubation with the beads.
(D) pBY3047 (rhgf-2::SnAvi in pTriEx) is used for expression of SnAvi-tagged proteins both E. coli as well as in HEK293T cells (in this case
co-transfected with birA), biotinylated RHGF-2::SnAvi protein can be detected in the crude lysates of both expression systems. (E) Recombinant
DJR-1.1::SnAvi expressed in HEK293T cells can only bind to avidin-beads when birA is co-transfected. Furthermore, DJR-1.1::SB1 (indicated by an
asterisk) is detected after elution with the TEV-protease and enriched with SB1-coupled Protein A/G Sepharose (Santa Cruz). The heavy and light
antibody chains are recognized by the secondary mouse antibody (ab HC and ab LC), indicated by ﬁlled arrow heads. Endogenously biotinylated
proteins are indicated by unﬁlled arrow heads. In addition to the full-length proteins some partial or degraded protein products can be detected in
(B)-(E). The detection for (B) and (C) was done with a-GFP antibodies (rabbit, Abcam, 1:2000), for (D) with a-GFP antibodies (mouse, Roche,
1:1000), and for (E) with the SB1 antibody (mouse, 4.6mg/ml). Fluorescent secondary antibodies were used for detection in combination with the
Odyssey (LI-COR). In (D) and (E) additionally Alexa 680 coupled streptavidin was used for detection.
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from C. elegans
Since the SnAvi-Tag was proven to be an eﬀective tool for
protein puriﬁcations in HEK293T cells and in E. coli,
we wanted to test it in a system in which tandem aﬃnity
puriﬁcation has not yet been established as a canonical
method. Therefore, we decided to purify SnAvi-tagged
proteins and protein complexes from C. elegans lysates.
For this purpose, we cloned the chn-1 coding sequence
as fusion to the SnAvi-Tag coding sequence. To restrict
the expression of CHN-1::SnAvi to the body wall muscle
of C. elegans the myo-3 promoter was chosen. The same
promoter was used to express the birA::mCherry fusion.
Both plasmids that additionally carried an element to
rescue the unc-119 mutant phenotype were mixed and
injected (33) in unc-119(ed3) to yield the transgenic
C. elegans strain BR5072. As shown in Figure 4 both
fusion proteins can be detected in the body wall muscle
of transgenic animals.
To purify SnAvi-tagged CHN-1 transgenic animals
were grown in liquid culture. Protein lysates were
incubated with avidin beads to bind CHN-1::SnAvi. The
beads were washed and then used for the TEV-cleavage
procedure. For the last step of the puriﬁcation SB1
antibody covalently coupled to Protein G agarose was
used to bind CHN-1::SB1 along with its complex
partners. The bound proteins were eluted from the beads
and completely used for analysis with two-dimensional
(2D) LC-MS/MS tandem MS.
Several proteins were identiﬁed by MS (Table 1).
Proteins that were also identiﬁed in CHN-1 unrelated
experiments were considered as unspeciﬁc and subtracted.
In these control experiments, the only interaction partner
that was speciﬁcally puriﬁed with the SnAvi tag was the
C. elegans protein NAS-37 that thus was included in our
background subtraction list (data not shown). Among the
remaining identiﬁed proteins, CHN-1 was abundant.
In addition to CHN-1, HSP-1 was identiﬁed as complex
partner. Interestingly, the human CHN-1 orthologue
CHIP was originally described as interaction partner
of Hsp70 (38). CHIP interacts with the C-terminus
of Hsp70 and was even named after this interaction
(C terminus of Hsp70 interacting protein). For instance,
CHIP and Hsp70 are known to act together in a complex
Figure 4. Expression of myo-3::birA::mCherry and myo-3::chn-1::SnAvi in C. elegans. The worm strain BR5072 carries the transgene byEx715. This
transgenic array allows expression of both birA::mCherry and CHN-1::SnAvi in the body wall muscle of C. elegans. The upper animal is an adult
hermaphrodite, whereas the lower is a L4-larva. For both animals anterior is left. Scale bar: 100mm. (A) Diﬀerential interference contrast image:
(B) mCherry-ﬂuorescence; (C) GFP-ﬂuorescence; and (D) merge.
Table 1. Identiﬁcation of CHN-1 interactors with 2D-LC-MS/MS
Caenorhabditis
elegans protein
Protein
mass (KDa)
Amino
acids
Amino acids
identiﬁed by
MS-analysis
Peptide
coverage,
n %
CHN-1 31.1 266 73 27.4
HSP-1 69.7 640 54 8.4
UBC-25 44.1 387 16 4.1
CHN-1 complexes were puriﬁed by tandem puriﬁcation using the
SnAvi-Tag and SB1-coupled protein G agarose. Puriﬁed proteins
were analysed by 2D LC-MS/MS. Proteins that were also recognized
in other CHN-1 unrelated experiments were considered as unspeciﬁc
and thus subtracted.
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tion and degradation of the unfolded cystic ﬁbrosis
transmembrane conductance regulator protein CFTR
(39), thus validating a physiological relevance of this
interaction.
Since we also identiﬁed the Hsp70 homologue CeHSP-1
as interactor for the C. elegans CHIP orthologue CHN-1
we conclude that this interaction is important and
conserved among species.
Furthermore, we also identiﬁed the E2 ubiquitin-ligase
UBC-25 which plausibly could form a functional complex
with the E3/E4 ubiquitin transferase CHN-1. Interest-
ingly, this interaction was also found in the vice versa
experiment in which the puriﬁcation procedure was per-
formed with UBC-25::SnAvi. Here, CHN-1 was identiﬁed
with MS as the most prominent co-puriﬁed protein (data
not shown).
Investigation of the CHN-1 and UBC-25 interaction
in vivo
To verify the interaction of CHN-1 and UBC-25 with
a SnAvi-tag independent method the C. elegans strain
BR5518 was generated and used for microscopic
analysis. This strain carries both the translational fusion
chn-1::Cerulean under control of the myo-3 promoter as
well as the ubc-25::Venus translational fusion under
control of the ubc-25 promoter. In optical sections both
protein fusions clearly co-localized in not further char-
acterized cytosolic structures of the body wall muscle
cells (Figure 5B). In addition, UBC-25::Venus was
detected in the nucleus as described previously (31).
Moreover, we were able to measure FRET signals in
regions where co-localization of UBC-25 and CHN-1
occurred (Figure 5E). These results suggest that the
distance between Cerulean and Venus does not exceed
more than 7–10nm, indicating a molecular interaction.
DISCUSSION
Many proteins exert their function within protein
complexes. Thus, the isolation and identiﬁcation of com-
ponents of protein complexes may extend our understand-
ing of their physiological role. However, to purify a tagged
protein requires reagents with a high binding aﬃnity to
the target protein as well as low cross-reactivity with other
unrelated proteins. One possible approach to increase
sample purity is the use of TAP strategies, most promi-
nent among them the original TAP-tag (2). This tag is
composed of an IgG-binding domain and of the CBP.
It was used very successfully for the puriﬁcation of
Figure 5. UBC-25 and CHN-1 are interacting in C.elegans in vivo. The worm strain BR5518 carries the transgene byEx780. This enables the
expression of UBC-25::Venus under control of its natural promoter and CHN-1::Cerulean expression in the body wall muscle of the animals.
A L3-stage larva is shown. Optical sections of the animal were analysed with a Zeiss LSM510-META inverted confocal laser scanning microscope.
Scale bar: 10mm. (A) Diﬀerential interference contrast image. (B) The merged image of UBC-25::Venus (green) and CHN-1::Cerulean (red) shows a
partial co-localization of both proteins. (C) CHN-1::Cerulean ﬂuorescence. (D) UBC::25::Venus ﬂuorescence. (E) FRET eﬃciency colour encoded
from 0% (dark blue) to 25% (red).
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several drawbacks for the work with other cell types. We
recognized in our initial experiments that the CBP domain
did not bind to the calmodulin aﬃnity matrix if it was
expressed in C. elegans. A possible reason for this could
be a strong binding of endogenous proteins of this species
directly to the tag structure. Here, we demonstrate that
our newly designed tandem tag, the SnAvi-Tag, is able
to overcome these problems. The AviTag (15) is used for
the ﬁrst step of the puriﬁcation that is based on the high
aﬃnity interaction of biotin to (strept-)avidin. It has
previously been employed for chromatin puriﬁcation
and allows the use of 10 times less amount of protein
compared to the classical antibody-based chromatin
immunoprecipitation (ChIP) experiment (40). Further-
more, it enables the application of more stringent
washing conditions in order to improve purity. Therefore,
the SnAvi-Tag should be applicable for ChIP-like
approaches as well as for the identiﬁcation of low-
abundant protein complexes. The latter is of special
importance because the mass action law sets a deﬁned
limit to the application of all other aﬃnity tags, whose
KD is many orders of magnitudes higher.
In addition to the AviTag the SnAvi-Tag encodes
EGFP for the visualization of protein fusions in vivo.
This allows the assessment of the expression and func-
tionality of protein fusions. Only if green ﬂuorescence is
visible and is localized to the expected sub-cellular com-
partments the fusion protein can be expected to achieve
the proper physiological function.
Another advantage of the AviTag for the work with
multicellular model organisms is the requirement of an
enzymatic activation of this tag. Since we can express
the E. coli protein biotin ligase birA in a tissue speciﬁc
manner, we can selectively purify proteins from a target
cell type, regardless of the expression pattern of the
SnAvi-tagged protein. This is of special importance for
small model organisms, such as C. elegans, in which cell
fractionation of post-embryonic stages is impossible. Until
now, it was only possible to purify proteins from a speciﬁc
subset of C. elegans cells when tissue speciﬁc promoters
were used to express a tagged protein. Often, it is not
an easy task to ﬁnd a promoter that results in appropri-
ate expression levels in the required tissue. With our tag
system, it is now possible to use the endogenous promoter.
The tissue speciﬁcity is obtained by the cell-speciﬁc expres-
sion of birA, since biotinylated SnAvi-tagged protein is
produced only in those cells in which both promoters
are active. The AviTag is not biotinylated by the birA
C. elegans orthologue BPL-1 which was tested in prelim-
inary experiments (data not shown). Compared to other
enzymatically activated tag-systems, such as the Halo-Tag
(41) or the SNAP-Tag (42), the SnAvi-Tag has one major
advantage: its co-factor D-biotin is an essential vitamin
and must be taken up by every cell to ensure its survival.
Therefore, it is available in every cell of the organism. In
contrast to this, the SNAP-tag and the Halo-tag need the
presence of artiﬁcial small molecules to label the tagged
protein. Thus, these tags can only be used if all cells inter-
nalize the required compounds. This sets serious
limitations to the application of these tags in multicellular
model organisms.
A relevant disadvantage of the AviTag is the presence of
endogenously biotinylated proteins, such as carboxylases
in all eukaryotic cells that will be co-puriﬁed with (strept-)
avidin in the ﬁrst aﬃnity puriﬁcation. However, a speciﬁc
elution of the tagged protein from the ﬁrst aﬃnity matrix
is already achieved by TEV-protease cleavage. This allows
the elution of the tagged protein from the (strept-)avidin
column material using non-denaturing conditions, thus
preserving protein complexes.
In a second step, the tagged protein and its complex
binding partners are further puriﬁed using the SB1
antibody. The SB1-producing hybridoma cell line is
publicly shared and distributed. In this study, we
mapped the epitope recognized by this antibody and
introduced it as a part of the SnAvi-Tag. We could show
that this antibody speciﬁcally recognizes the SB1-epitope
without cross reactivity in diverse expression systems
including E. coli, vertebrate cell culture, and C. elegans.
One major concern is steric hindering of native protein
complex formation by tag structures. We propose that the
long unfolded amino acid stretch in the SnAvi-Tag
composed of two SB1 and two TEV-recognition sites
should reduce such eﬀects.
In order to demonstrate the eﬃcacy of the SnAvi-Tag in
C. elegans, we investigated the E3/E4 ubiquitin-protein
ligase CHN-1 in body-wall muscle cells. These ligases
typically function in the context of heterologous multi-
protein complexes (43). Since we are interested in disease
relevant functions of CHN-1 and other members of the
ubiquitylation machinery (44–46) we selected this protein
as a demonstration target. Together with CHN-1::SnAvi
we could co-purify known as well as new complex
components, including UBC-25. Vice versa, CHN-1 was
co-precipitated using UBC-25::SnAvi (data not shown).
Moreover, we were able to proof the interaction of
UBC-25 and CHN-1 with a SnAvi-tag independent
method in vivo. For this purpose, transgenic animals
carrying CHN-1::Cerulean and UBC-25::Venus were
generated and analysed in FRET experiments. Taken
together, we have evidence of CHN-1 being indeed an
interaction partner of UBC-25, demonstrating that the
SnAvi-Tag is a suitable tool for protein complex puriﬁca-
tions even from whole animals.
In summary, we could show that the SnAvi-Tag is
eﬃcient in a broad range of organisms in ﬁve basic appli-
cations: (i) for in vivo imaging of protein fusions; (ii) for
immunoprecipitation with the SB1 antibody; (iii) for
single-step aﬃnity puriﬁcation using (strept-)avidin;
(iv) for tandem aﬃnity puriﬁcation employing in vivo
biotinylation, streptavidin binding, mild TEV-protease
elution and ﬁnal puriﬁcation using the SB1 antibody;
and (5) for cell-type-speciﬁc protein interaction studies
in small multicellular model organisms.
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